Share
Preview
Investments on Propel(x) are high risk, illiquid and bear the risk of partial or complete loss of invested capital. Please review risk factors for investments on Propel(x) here.
This newsletter is for informational purposes only. It is not a solicitation to buy or sell a security.

Were you forwarded this newsletter? Subscribe here
                     15 July 2021                      
Alumni Spotlight
 
Medcura

Medcura is a commercial-stage medical device company developing versatile hemostatic products for surgical, medical and consumer applications.

 
Newsflash - Earlier this week, Medcura announced the launch of a high performance, antibacterial hemostatic wound gel available online and through a leading drugstore in the U.S. market. The gel has been custom designed to meet an unmet market need, especially for irregular injuries where bandages can be inconvenient, and powders are messy and can cause discomfort. Read the press release.

Fun Fact - Did you know Medcura has been endorsed by Stephen Hawking? Watch his video.

Disclosure : Medcura is a Propel(x) alumni company and closed fundraising through the platform in April 2017, June 2018 and July 2021.
 
InsightFinder

InsightFinder provides innovative machine learning technology to unlock the value in IT operational data, from performance metrics to textual log files, finding root causes for deviations from normal behaviors and recurring patterns, as well as predicting future events and outages, involving a company's operational staff only when necessary and appropriate to do so.

 
Newsflash - InsightFinder recently announced new customers, leadership, and funding from leading VC funds to meet growing demand for its AIOps technology. Read the press release.

Disclosure : InsightFinder is a Propel(x) alumni company and closed fundraising through the platform in February 2018.
 
Preferred Stock vs. Common Stock in Startups
In this blog post, we provide an overview of “preferred stock” and “common stock” for an investor who is considering investment opportunities in startups. Note that this is a very broad topic requiring careful consideration, so the information provided is not exhaustive – as always when it comes to investing in startups, doing your own due diligence is a critical part of the process.

It is helpful to understand the terms ‘common stock’ and ‘preferred stock’ in the context of public markets first. With that baseline understanding, we can move on to the discussion in the context of private markets.
From The Archives
 
 
As Richard Branson introduced the potential of space tourism earlier this week, we were reminded of our 'Investing in Space - Humanity's Ultimate Business Plan' blog post which we published last year.

ICYMI, here are some of the interesting blog posts which we have written in the past. We will be releasing a line up of new content in the next few weeks. Stay tuned by subscribing to our blog.
 
DEEP TECHNOLOGY BUZZ
 
Here is what caught our attention over the past two weeks.
We are reading
How would you rate our newsletter?
Propel(x) is a premier digital platform facilitating private venture capital for deep            technology startups. Our mission is to enable investment in technologies that matter
and thus build the next generation of great companies.

Investors | Founders


Investments on Propel(x) are high risk, illiquid and bear the risk of partial or complete loss of invested capital. Please review risk factors for investments on Propel(x)
here.

 
 
 


Email Marketing by ActiveCampaign